Lithium Controlled-Release and Extended-Release Tablets and Onasemnogene Abeparvovec
Determining the interaction of Lithium Controlled-Release and Extended-Release Tablets and Onasemnogene Abeparvovec and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lithium
Brand name: Lithobid, Eskalith, Lithonate, Lithotabs, Eskalith-CR
Synonyms: Lithium
Generic Name: onasemnogene abeparvovec
Brand name: Zolgensma, Zolgensma
Synonyms: Onasemnogene abeparvovec (Zolgensma)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lithium Controlled-Release and Extended-Release Tablets-Onasemnogene abeparvovec Zolgensma
- Lithium Controlled-Release and Extended-Release Tablets-Oncaspar
- Lithium Controlled-Release and Extended-Release Tablets-Oncovin
- Lithium Controlled-Release and Extended-Release Tablets-Ondansetron
- Lithium Controlled-Release and Extended-Release Tablets-Ondansetron and Dextrose
- Lithium Controlled-Release and Extended-Release Tablets-Ondansetron Hydrochloride
- Onasemnogene Abeparvovec-Lithium ER
- Onasemnogene Abeparvovec-Lithium Oral Solution
- Onasemnogene Abeparvovec-Lithium Salts
- Onasemnogene Abeparvovec-Lithium Syrup and Oral Solution
- Onasemnogene Abeparvovec-Lithobid
- Onasemnogene Abeparvovec-Lithostat